Go Pro

Spire Healthcare Group (SPI) Competitors

Spire Healthcare Group logo
GBX 242 +1.00 (+0.41%)
As of 12:18 PM Eastern

SPI vs. UDG, UPR, MGP, SBI, and OHGR

Should you buy Spire Healthcare Group stock or one of its competitors? Spire Healthcare Group's main competitors and comparable companies include UDG Healthcare (UDG), Uniphar (UPR), Medica Group (MGP), Sourcebio International (SBI), and One Health Group (OHGR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Spire Healthcare Group compare to UDG Healthcare?

Spire Healthcare Group (LON:SPI) and UDG Healthcare (LON:UDG) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk.

21.8% of Spire Healthcare Group shares are owned by institutional investors. 39.3% of Spire Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Spire Healthcare Group presently has a consensus price target of GBX 245, indicating a potential upside of 1.24%. Given Spire Healthcare Group's stronger consensus rating and higher possible upside, equities analysts plainly believe Spire Healthcare Group is more favorable than UDG Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Spire Healthcare Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
UDG Healthcare
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Spire Healthcare Group has higher revenue and earnings than UDG Healthcare. UDG Healthcare is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Spire Healthcare Group£1.58B0.61£28.15M£4.0060.50
UDG Healthcare£1.25B0.00N/A£25.40N/A

In the previous week, Spire Healthcare Group had 4 more articles in the media than UDG Healthcare. MarketBeat recorded 4 mentions for Spire Healthcare Group and 0 mentions for UDG Healthcare. Spire Healthcare Group's average media sentiment score of 0.17 beat UDG Healthcare's score of 0.00 indicating that Spire Healthcare Group is being referred to more favorably in the media.

Company Overall Sentiment
Spire Healthcare Group Neutral
UDG Healthcare Neutral

Spire Healthcare Group pays an annual dividend of GBX 2.30 per share and has a dividend yield of 1.0%. UDG Healthcare pays an annual dividend of GBX 0.17 per share. Spire Healthcare Group pays out 57.5% of its earnings in the form of a dividend. UDG Healthcare pays out 0.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Spire Healthcare Group has a net margin of 1.04% compared to UDG Healthcare's net margin of 0.00%. Spire Healthcare Group's return on equity of 2.22% beat UDG Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Spire Healthcare Group1.04% 2.22% 3.73%
UDG Healthcare N/A N/A N/A

Summary

Spire Healthcare Group beats UDG Healthcare on 13 of the 15 factors compared between the two stocks.

How does Spire Healthcare Group compare to Uniphar?

Uniphar (LON:UPR) and Spire Healthcare Group (LON:SPI) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

Uniphar has a net margin of 1.66% compared to Spire Healthcare Group's net margin of 1.04%. Uniphar's return on equity of 13.14% beat Spire Healthcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Uniphar1.66% 13.14% 3.76%
Spire Healthcare Group 1.04%2.22%3.73%

Uniphar pays an annual dividend of GBX 1.96 per share and has a dividend yield of 0.6%. Spire Healthcare Group pays an annual dividend of GBX 2.30 per share and has a dividend yield of 1.0%. Uniphar pays out 10.1% of its earnings in the form of a dividend. Spire Healthcare Group pays out 57.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

In the previous week, Spire Healthcare Group had 4 more articles in the media than Uniphar. MarketBeat recorded 4 mentions for Spire Healthcare Group and 0 mentions for Uniphar. Spire Healthcare Group's average media sentiment score of 0.17 beat Uniphar's score of 0.00 indicating that Spire Healthcare Group is being referred to more favorably in the news media.

Company Overall Sentiment
Uniphar Neutral
Spire Healthcare Group Neutral

Uniphar presently has a consensus target price of GBX 480, indicating a potential upside of 35.55%. Spire Healthcare Group has a consensus target price of GBX 245, indicating a potential upside of 1.24%. Given Uniphar's higher possible upside, analysts plainly believe Uniphar is more favorable than Spire Healthcare Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Uniphar
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Spire Healthcare Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Uniphar has a beta of 1.102, suggesting that its share price is 10% more volatile than the broader market. Comparatively, Spire Healthcare Group has a beta of 0.933, suggesting that its share price is 7% less volatile than the broader market.

Uniphar has higher revenue and earnings than Spire Healthcare Group. Uniphar is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Uniphar£3.07B0.30£51.04M£19.5018.16
Spire Healthcare Group£1.58B0.61£28.15M£4.0060.50

36.9% of Uniphar shares are owned by institutional investors. Comparatively, 21.8% of Spire Healthcare Group shares are owned by institutional investors. 7.9% of Uniphar shares are owned by insiders. Comparatively, 39.3% of Spire Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Uniphar beats Spire Healthcare Group on 10 of the 16 factors compared between the two stocks.

How does Spire Healthcare Group compare to Medica Group?

Medica Group (LON:MGP) and Spire Healthcare Group (LON:SPI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings, media sentiment and analyst recommendations.

Medica Group has a beta of 1.1, meaning that its share price is 10% more volatile than the broader market. Comparatively, Spire Healthcare Group has a beta of 0.933, meaning that its share price is 7% less volatile than the broader market.

In the previous week, Spire Healthcare Group had 4 more articles in the media than Medica Group. MarketBeat recorded 4 mentions for Spire Healthcare Group and 0 mentions for Medica Group. Spire Healthcare Group's average media sentiment score of 0.17 beat Medica Group's score of 0.00 indicating that Spire Healthcare Group is being referred to more favorably in the news media.

Company Overall Sentiment
Medica Group Neutral
Spire Healthcare Group Neutral

Spire Healthcare Group has a consensus price target of GBX 245, suggesting a potential upside of 1.24%. Given Spire Healthcare Group's stronger consensus rating and higher probable upside, analysts clearly believe Spire Healthcare Group is more favorable than Medica Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medica Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Spire Healthcare Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

88.4% of Medica Group shares are owned by institutional investors. Comparatively, 21.8% of Spire Healthcare Group shares are owned by institutional investors. 2.9% of Medica Group shares are owned by company insiders. Comparatively, 39.3% of Spire Healthcare Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Medica Group pays an annual dividend of GBX 3 per share. Spire Healthcare Group pays an annual dividend of GBX 2.30 per share and has a dividend yield of 1.0%. Medica Group pays out 5,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Spire Healthcare Group pays out 57.5% of its earnings in the form of a dividend. Spire Healthcare Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

Medica Group has a net margin of 9.35% compared to Spire Healthcare Group's net margin of 1.04%. Medica Group's return on equity of 12.42% beat Spire Healthcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Medica Group9.35% 12.42% 6.62%
Spire Healthcare Group 1.04%2.22%3.73%

Spire Healthcare Group has higher revenue and earnings than Medica Group. Medica Group is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medica Group£76.98M0.00£7.20M£0.06N/A
Spire Healthcare Group£1.58B0.61£28.15M£4.0060.50

Summary

Spire Healthcare Group beats Medica Group on 11 of the 17 factors compared between the two stocks.

How does Spire Healthcare Group compare to Sourcebio International?

Sourcebio International (LON:SBI) and Spire Healthcare Group (LON:SPI) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability.

Spire Healthcare Group has a net margin of 1.04% compared to Sourcebio International's net margin of 0.00%. Spire Healthcare Group's return on equity of 2.22% beat Sourcebio International's return on equity.

Company Net Margins Return on Equity Return on Assets
Sourcebio InternationalN/A N/A N/A
Spire Healthcare Group 1.04%2.22%3.73%

Spire Healthcare Group has a consensus target price of GBX 245, indicating a potential upside of 1.24%. Given Spire Healthcare Group's stronger consensus rating and higher probable upside, analysts plainly believe Spire Healthcare Group is more favorable than Sourcebio International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sourcebio International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Spire Healthcare Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Spire Healthcare Group had 4 more articles in the media than Sourcebio International. MarketBeat recorded 4 mentions for Spire Healthcare Group and 0 mentions for Sourcebio International. Spire Healthcare Group's average media sentiment score of 0.17 beat Sourcebio International's score of 0.00 indicating that Spire Healthcare Group is being referred to more favorably in the news media.

Company Overall Sentiment
Sourcebio International Neutral
Spire Healthcare Group Neutral

21.8% of Spire Healthcare Group shares are held by institutional investors. 39.3% of Spire Healthcare Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Spire Healthcare Group has higher revenue and earnings than Sourcebio International. Sourcebio International is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sourcebio International£75.61M0.00N/A£0.09N/A
Spire Healthcare Group£1.58B0.61£28.15M£4.0060.50

Summary

Spire Healthcare Group beats Sourcebio International on 12 of the 13 factors compared between the two stocks.

How does Spire Healthcare Group compare to One Health Group?

One Health Group (LON:OHGR) and Spire Healthcare Group (LON:SPI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation.

In the previous week, Spire Healthcare Group had 4 more articles in the media than One Health Group. MarketBeat recorded 4 mentions for Spire Healthcare Group and 0 mentions for One Health Group. Spire Healthcare Group's average media sentiment score of 0.17 beat One Health Group's score of 0.00 indicating that Spire Healthcare Group is being referred to more favorably in the news media.

Company Overall Sentiment
One Health Group Neutral
Spire Healthcare Group Neutral

12.5% of One Health Group shares are owned by institutional investors. Comparatively, 21.8% of Spire Healthcare Group shares are owned by institutional investors. 46.1% of One Health Group shares are owned by insiders. Comparatively, 39.3% of Spire Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Spire Healthcare Group has higher revenue and earnings than One Health Group. One Health Group is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
One Health Group£31.59M1.24N/A£14.9819.39
Spire Healthcare Group£1.58B0.61£28.15M£4.0060.50

Spire Healthcare Group has a consensus target price of GBX 245, suggesting a potential upside of 1.24%. Given Spire Healthcare Group's stronger consensus rating and higher probable upside, analysts plainly believe Spire Healthcare Group is more favorable than One Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
One Health Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Spire Healthcare Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Spire Healthcare Group has a net margin of 1.04% compared to One Health Group's net margin of 0.00%. Spire Healthcare Group's return on equity of 2.22% beat One Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
One Health GroupN/A N/A N/A
Spire Healthcare Group 1.04%2.22%3.73%

One Health Group pays an annual dividend of GBX 6.23 per share and has a dividend yield of 2.1%. Spire Healthcare Group pays an annual dividend of GBX 2.30 per share and has a dividend yield of 1.0%. One Health Group pays out 41.6% of its earnings in the form of a dividend. Spire Healthcare Group pays out 57.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. One Health Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Spire Healthcare Group beats One Health Group on 11 of the 16 factors compared between the two stocks.

Get Spire Healthcare Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SPI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SPI vs. The Competition

MetricSpire Healthcare GroupHealthcare Providers & Services IndustryHealthcare SectorLON Exchange
Market Cap£969.45M£10.09B£7.28B£2.91B
Dividend Yield0.63%2.59%2.53%6.18%
P/E Ratio60.5034.59272.42367.42
Price / Sales0.614.96623.3883,891.79
Price / Cash9.12121.7577.3927.89
Price / Book1.323.9912.856.75
Net Income£28.15M£313.25M£3.47B£5.89B
7 Day Performance2.98%1.03%1.24%5.57%
1 Month Performance4.09%0.29%5.81%2.30%
1 Year Performance13.08%15.42%25.75%21.81%

Spire Healthcare Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SPI
Spire Healthcare Group
1.0068 of 5 stars
GBX 242
+0.4%
GBX 245
+1.2%
+13.9%£969.45M£1.58B60.50420
UDG
UDG Healthcare
N/AN/AN/AN/A£2.72B£1.25B42.489,000
UPR
Uniphar
N/AGBX 354.11
-0.3%
GBX 480
+35.6%
+1.8%£919.18M£3.07B18.163,000
MGP
Medica Group
N/AN/AN/AN/A£259.85M£76.98M3,516.671,212
SBI
Sourcebio International
N/AN/AN/AN/A£85.31M£75.61M1,277.78194

Related Companies and Tools


This page (LON:SPI) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners